| 09/08/2026 6:33 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2026 6:36 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/14/2026 4:19 PM | enGene (1980845) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 3:49 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 7:25 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 10:40 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 08/11/2026 3:03 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2026 3:05 PM | enGene (1980845) Issuer Richton Kathleen P. (2145406) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/22/2026 3:05 PM | Chinoporos Constantine (2014509) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/22/2026 8:14 AM | ACORN BIOVENTURES, L.P. (1766853) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 07/17/2026 3:05 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ENGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/16/2026 7:06 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 3:06 PM | enGene (1980845) Filer | Form 8-K/A | |
| 06/17/2026 4:35 PM | enGene (1980845) Issuer Zoth Lota S. (1278219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:38 PM | enGene (1980845) Issuer Heffernan Michael Thomas (1448914) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:39 PM | enGene (1980845) Issuer HASTINGS PAUL J (1309702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:40 PM | enGene (1980845) Issuer Grossman William (1730229) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:41 PM | enGene (1980845) Issuer Glickman Richard M (1352637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:43 PM | BRUNK GERALD A (1380226) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:44 PM | Astley-Sparke Philip (1376491) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:37 PM | enGene (1980845) Issuer Joustra Wouter (1897813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 8:14 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 8:16 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/10/2026 3:09 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 12:12 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 9:30 AM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 8:23 PM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 05/08/2026 3:06 PM | enGene (1980845) Filer | Form DEF 14A | |
| 05/07/2026 6:11 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 9:59 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 04/09/2026 3:02 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 11:20 AM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:25 AM | enGene (1980845) Filer | Form 424B5 | |
| 03/09/2026 6:09 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/09/2026 6:15 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:04 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | enGene (1980845) Filer | Form EFFECT | |
| 02/19/2026 3:25 PM | enGene (1980845) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/17/2026 5:09 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 2:00 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 02/17/2026 11:46 AM | enGene (1980845) Subject Kynam Capital Management, LP (1907884) Filed by | Form SCHEDULE 13G/A | |
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad) A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. See the ticker behind this Grand Canyon energy breakthrough now |
| 01/27/2026 1:18 PM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 6:38 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:11 PM | enGene (1980845) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:04 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:12 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 6:01 AM | enGene (1980845) Filer | Form 424B5 | |
| 11/12/2025 5:16 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 6:36 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |